Dr. Giuseppe Morelli, MD

Dr. Morelli practices at Lakeview Regional Medical Center in Covington, Louisiana.

Dr. Morelli's NPI, 1962461004, was assigned on March 18, 2006. Dr. Morelli graduated from Creighton University School of Medicine - Omaha in 1994. Dr. Morelli's Louisiana license number on file is 342098.

Dr. Morelli's primary practice is Lakeview Regional Medical Center, at 95 Judge Tanner Blvd, Covington, LA 70433 in Saint Tammany Parish. The practice phone is (504) 503-4000.

Dr. Morelli's primary practice is Lakeview Regional Medical Center in Covington, Louisiana. Dr. Morelli is also affiliated with UF Health Shands Hospital. The medical group on file is Tulane Doctors. Dmand AI also links Dr. Morelli to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morelli practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Morelli's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Morelli is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Morelli's licenses on file in 4 states: Louisiana, South Carolina, Florida and Ohio.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver, hepatitis c, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Morelli treats.

CMS data shows 199 Medicare services from Dr. Morelli across 4 procedure codes in 2024, for 201 Medicare patients. Medicare paid $16,369 for them.

CMS counts 201 Medicare patients who saw Dr. Morelli in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morelli's median patient age at 66, with 47% women.

In 2024, Dr. Morelli wrote 585 Medicare Part D claims for 104 patients. 82% of them were for generic drugs. CMS names the drug for 489 of them, across 16 drugs with 11 or more claims each, at $297,727 in total drug cost. In 2023, CMS named 539 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Morelli for performance year 2024, reported through an alternative payment model (APM). Dr. Morelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Morelli, published from 2007 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Liver Transplantation, Drug Therapy, Combination and Antiviral Agents. Dr. Morelli has published most often in Aliment Pharmacol Ther. Dr. Morelli's most frequent co-authors are Consuelo C. Soldevila-Pico, MD, Roniel Cabrera, MD and Virginia Catherine Clark, MD.

Dmand AI links Dr. Morelli to 3 clinical trials. Conditions studied include Ascites, Hepatitis C and Hypertension, Portal.

CMS Open Payments shows 76 general payments to Dr. Morelli from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Gilead Sciences, Inc. paid the most, $863. It also lists 2 research payments totaling $12,476 from 2016 to 2025.

Dmand AI lists 1 award for Dr. Morelli, most recently CMS Stage 1 EHR in 2013.

Dr. Morelli graduated from Creighton University School of Medicine - Omaha in 1994.

Dr. Morelli is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.